Search

Search Constraints

You searched for: Author/Creator Dapavo, P.

Search Results

3. Brodalumab efficacy in bio-naïve psoriasis patients: real-life experience of 202 subjects up to 48 weeks. (17th November 2022)

4. Brodalumab for the treatment of moderate‐to‐severe plaque‐type psoriasis: a real‐life, retrospective 24‐week experience. (13th October 2020)

5. Chilblain acral lesions in the COVID‐19 era. Are they marker of infection in asymptomatic patients?. (8th June 2020)

6. Comparison of Secukinumab and Ixekizumab in psoriasis: a real‐life cohort study on the efficacy and drug survival of 445 patients. (7th November 2021)

7. Consensus on the management of patients with psoriatic arthritis in a dermatology setting. (11th January 2018)

8. Consensus on the place in therapy of TNF‐α inhibitors in the treatment of patients with chronic plaque psoriasis. (20th May 2020)

9. Creation of a severity index for hidradenitis suppurativa that includes a validated quality‐of‐life measure: the HIDRAscore. (12th May 2020)

10. Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in adult cohort: a real‐life Italian tertiary centre experience. (22nd May 2020)